Evidence map›Paper›PMID 36897879›Full record

ArticlePloS one2023

Cytokine profiling of samples positive for Chlamydia trachomatis and Human papillomavirus.

Larissa Zatorre Almeida Lugo, Marco Antonio Moreira Puga, Camila Mareti Bonin Jacob, Cacilda Tezelli Junqueira Padovani, Mariana Calarge Nocetti, Maisa Souza Tupiná, Ana Flávia Silva Pina, Jennifer Naed Martins de Freitas, Alda Maria Teixeira Ferreira, Carlos Eurico Dos Santos Fernandes and 3 more

Open access · goldFull text read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Clinical application of modified Yihuang Decoction for the treatment of cervical high-risk HPV persistent infection.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2026
    Article
  2. Review
  3. Article
  4. UnveilingiScience · 2025
    Article
  5. Article
  6. Article
  7. A TriAdj-AdjuvantedVaccines · 2024
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Larissa Zatorre Almeida LugoPostgraduate Program of Infectious and Parasitary Diseases from Medicine School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Marco Antonio Moreira PugaPostgraduate Program of Infectious and Parasitary Diseases from Medicine School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.ORCID 0000-0002-6514-537X
Camila Mareti Bonin JacobBioscience Institute from the Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Cacilda Tezelli Junqueira PadovaniBioscience Institute from the Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Mariana Calarge NocettiFaculdade de Ciências Farmacêuticas, Nutrição e Alimentos, UFMS, Campo Grande, Mato Grosso do Sul, Brazil.
Maisa Souza TupináMedicine School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Ana Flávia Silva PinaMedicine School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Jennifer Naed Martins de FreitasPostgraduate Program of Infectious and Parasitary Diseases from Medicine School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Alda Maria Teixeira FerreiraBioscience Institute from the Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Carlos Eurico Dos Santos FernandesBioscience Institute from the Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Adriane Cristina BovoDepartment of Cancer Prevention, Barretos Cancer Hospital, Campo Grande, MS, Brazil.
Júlio César Possati ResendeDepartment of Cancer Prevention, Barretos Cancer Hospital, Barretos, São Paulo, Brazil.ORCID 0000-0002-7869-3885
Inês Aparecida TozettiPostgraduate Program of Infectious and Parasitary Diseases from Medicine School, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil.
Universidade Federal de Mato Grosso do Sul · BRHospital de Câncer de Barretos · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Persistent human papillomavirus (HPV) infection is closely associated with cervical carcinoma. Co-infection in the endocervical environment with other microorganisms, such as Chlamydia trachomatis, may increase the risk of HPV infection and neoplastic progression. While in some individuals, Chlamydia trachomatis infection is resolved with the activation of Th1/IFN-γ-mediated immune response, others develop a chronic infection marked by Th2-mediated immune response, resulting in intracellular persistence of the bacterium and increasing the risk of HPV infection. This work aimed to quantify cytokines of the Th1/Th2/Th17 profile in exfoliated cervix cells (ECC) and peripheral blood (PB) of patients positive for Chlamydia trachomatis DNA, patients positive for Papillomavirus DNA, and healthy patients. Cytokine levels were quantified by flow cytometry in ECC and PB samples from patients positive for C. trachomatis DNA (n = 18), patients positive for HPV DNA (n = 30), and healthy patients (n = 17) treated at the Hospital de Amor, Campo Grande-MS. After analysis, a higher concentration of IL-17, IL-6, and IL-4 (p <0.05) in ECC; INF-γ and IL-10 (p <0.05) in PB was found in samples from patients positive for C. trachomatis DNA compared to samples from healthy patients. When comparing samples from patients positive for HPV DNA, there was a higher concentration of cytokines IL-17, IL-10, IL-6, and IL-4 (p <0.05) in ECC and IL-4 and IL-2 (p <0.05) in PB of patients positive for C. trachomatis DNA. These results suggest that induction of Th2- and Th17 mediated immune response occurs in patients positive for C. trachomatis DNA, indicating chronic infection. Our results also demonstrate a high concentration of pro-inflammatory cytokines in ECC of patients positive for C. trachomatis DNA.

Indexed as

Chlamydia InfectionsPapillomavirus InfectionsChlamydia trachomatisCytokinesFemaleHuman Papillomavirus VirusesHumansInterleukin-10Interleukin-17Interleukin-4Interleukin-6PapillomaviridaePersistent InfectionCytokinesInterleukin-10Interleukin-17Interleukin-4Interleukin-6

Identifiers

PMID36897879
PMCPMC10004564
OpenAlexW4323812070

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read21
reference markers read5
identifiers read5
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.